News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Rumor: Pfizer Inc. (PFE) May Be Interested In Buying Bristol-Myers Squibb Company (BMY) After Losing AstraZeneca PLC (AZN)


6/17/2014 6:38:27 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

This week's tweet of the week comes from Patrick Crutcher of Chimera Research Group, who points out that if Bristol-Myers Squibb (NYSE: BMY ) becomes cheap enough, Pfizer (NYSE: PFE ) might be more interested in buying Bristol-Myers Squibb than it was in buying AstraZeneca (NYSE: AZN ) .

Bristol-Myers Squibb has seen a post-ASCO fall after investors were less than impressed with its immuno-oncology drugs. The pharma was priced at a premium, so it shouldn't be too surprising that any slip-up might result in a share-price drop.

Help employers find you! Check out all the jobs and post your resume.

Read at Motley Fool

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES